Elise Brownell
|
 |
About Elise Brownell, PhD. has spent the last 34 years in the bio/pharmaceutical arena where she has played key roles in Discovery, Development and Opportunity Assessment to drive innovation. After completing her doctorate, Elise’s career started at SUNY Stony Brook where she made discoveries relating to genetic evolution in the great apes. She continued her interest in comparative molecular biology during her tenure at Frederick Cancer Research Facility and expanded her facility with molecular genetics while in various functions at Bayer Healthcare. She played a pivotal role in directing discovery research in the areas of asthma, allergy, and immunology and continued her dedication to innovation by managing extramural collaborations for Bayer’s Biotechnology unit. Her efforts were widely recognized by promotion to Director, Project Management, where she led global cross-functional teams to bring several of Bayer’s biopharmaceuticals from bench to clinic. Her award winning performance at Bayer was followed by becoming a member of the founding team of a venture-backed spin out (Aerovance, Inc), where she became head of project management. During her tenure as Senior Director, Aerovance garnered over $60 MUSD, completed six clinical trials in 3.5 years, and built a right-sized matrixed organization. |
|
|
Connect on Social with Elise Brownell
How to Work with Me Contact us here. |
Our Philosophy In 2008, Elise co-founded ZephyrBiotech, LLC, a consulting practice that provides project leadership, management and planning to entrepreneurial life science companies, especially those that are early-stage, venture-backed entities. She also holds the title of Deal Flow Diva for the oldest professionally managed angel investment group in the Bay Area (The Angels’ Forum).
|